Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KLF1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | TBC1D22B | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | NDUFS2 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | DPM3 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | PRLH | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | ETV6 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | PABPC1 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | DMTN | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | AIFM1 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | MRPS21 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |